Grossmann M, Hoermann R, Gani L et al. Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clin. Endocrinol. (Oxf). 2012; 77: 323–8.
Monegal A, Navasa M, Guanabens N et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos. Int. 2001; 12: 484–92.
Puliyel MM, Vyas GP, Mehta GS. Testosterone in the management of cirrhosis of the liver—a controlled study. Aust. N. Z. J. Med. 1977; 7: 17–30.
Rambaldi A, Gluud C. Anabolic-androgenic steroids for alcoholic liver disease. Cochrane Database Syst. Rev. 2006; 4: CD003045.
Yurci A, Yucesoy M, Unluhizarci K et al. Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis. Clin. Res. Hepatol. Gastroenterol. 2011; 35: 845–54.